Model
Edge
Revance Therapeutics Inc.
0001793796
Filing Type
4
Filing Date
11/18/2024
Updated
11/19/24, 2:31 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership